跳至主要内容
临床试验/JPRN-UMIN000008712
JPRN-UMIN000008712招募中未知

Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventional - Effects of tolvaptan in patients undergoing pertoneal dialysis with heart failure

Division of Kidney and Hypertension, the Jikei University School of Medicine0 个研究点目标入组 40 人开始时间: 2012年8月17日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The patients showing allergy to tolvaptan or similar compound (ex. mozavaptan) 2)The patients showing allergy to sulfonamide 3)The anuric patients 4)The patients without a sense of thirst or ability to intake water 5)The patients with hypernatremia 6)The pregnant patients 7)The patients taking tolvaptan at the time of enrolling 8)The patitents in need of emergency medical care for massive heart failure 9)The patients given furosemide over 120mg/day at the time of enrolling 10)The patients with hepatic coma 11)The patients regarded as inappropriate for this clinical study by the principal investigator

研究者

发起方
Division of Kidney and Hypertension, the Jikei University School of Medicine

相似试验